Ram Mukunda
Tracked across 3 events · 18 articles · First seen Apr 28, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Author of the analysis questioning the AI-driven startup boom; his views shape the article's argument.
Jul 28, 2026 · 6 articles
Business
Impact: Ram Mukunda, CEO of IGC Pharma, emphasized the importance of engaging with caregivers to advance Alzheimer's research and support the CALMA trial's progress.
Apr 28, 2026 · 6 articles
Business
IGC Pharma, Inc. reported financial results for Q2 2026 and provided an update on its lead Alzheimer's program, IGC-AD1. The Phase 2 CALMA trial reached its 146-patient baseline randomization target and is within six randomizations…
Impact: As CEO, Ram Mukunda provided strategic updates and converted owed amounts into equity, aligning his interests with shareholders and preserving company cash.
Aug 17, 2026 · 6 articles
50
IGC Pharma converted debt to equity Ram MukundaIGC Pharma Q2 2026 CALMA...
ERGEN INTELLIGENCE
Track Ram Mukunda live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard